Wang Jing resigned as a nonexecutive director of China Resources Pharmaceutical Group Ltd. due to other work commitments.

Wang is the CFO of Beijing State-Owned Capital Operations and Management Center, or BSCOMC, an investment and asset management firm focused on China. BSCOMC is also an investor in China Resources, according to S&P Capital IQ data.

Concurrently, China Resources appointed Wang Shouye and Lu Ruizhi to its board as nonexecutive directors.

Lu is BSCOMC's general manager of the investment management second division.

Hong Kong-based China Resources is an investment holding company involved in the development and distribution of pharmaceutical and healthcare products in China and Hong Kong.